Case Study: Navigating Temporary Halts Through a Collaborative Approach Between Sponsors
Time: 1:00 pm
day: Day Two
Details:
- Discuss the challenges presented with temporary halts on gene therapy clinical trials
- How to successfully co-operate with regulatory agencies to renew proceedings
- What impacts do these halts have on the patient rare disease community?
- A collaborative approach: A mechanism to mitigate risks in gene therapy development programmes
